by | PRNewswire Asia
– XPOVIO® is the first XPO1 inhibitor approved for reimbursement by South Korea’s National Health Insurance Service (NHIS) for the treatment of adult patients with multiple myeloma (MM). – In South Korea, XPOVIO® has been approved for three...
by | PRNewswire Asia
HONG KONG, March 1, 2026 /PRNewswire/ — Médecins Sans Frontières (MSF) Hong Kong successfully held its large‑scale running and orienteering competition, "On Track to Save 2026", today at the Hong Kong Science Park. The event saw its...
by | PRNewswire Asia
SINGAPORE, Feb. 28, 2026 /PRNewswire/ — Orange Clove has been recognised as Singapore’s No. 1 Corporate Caterer[1] by Euromonitor International, based on 2024 customer value sales, having served over 830,000 guests that same year. The company has also...
by | PRNewswire Asia
NEW YORK and SEOUL, South Korea, Feb. 28, 2026 /PRNewswire/ — Korean skincare brand Purito Seoul has officially announced its new brand slogan, ‘From Soil to Seoul,’ Alongside this declaration, the brand will begin rolling out a series of...
by | PRNewswire Asia
Patent leadership reinforces company’s leading position in the global CBCT market HWASEONG, South Korea, Feb. 27, 2026 /PRNewswire/ — Vatech (KOSDAQ: 043150), a global manufacturer of dental imaging systems, announced that cumulative patent data over...
by | PRNewswire Asia
KUALA LUMPUR, Malaysia, Feb. 27, 2026 /PRNewswire/ — The ballroom shimmered with elegance, legacy and admiration as industry leaders, entrepreneurs, and close friends gathered in January to celebrate the 70th birthday of one of Malaysia’s most...